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INTRODUCTION 
Pharmaceutical industry in India is one of the fastest growing in the world. 
Exporting a significant percentage of generic drugs makes the pharmaceutical 
industry a leading player in the world market along with its application in the 
Research and Development (R&D). Research and Development in the pharma 
industry is multifaceted and draws upon the expertise of chemists, chemical 
engineers, pharmacologists and medical practitioners. The different activities of R&D 
include drug development (synthesis and manufacture), formulation, clinical trials, 
evaluations and finally launching. Closely associated with these are regulatory and 
quality assurance functions. The above functions require different manpower as 
synthetic chemists, analytical and quality control chemists, process development and 
manufacturing personnel (chemists and chemical engineers), pharmacologists for 
evaluation of drug delivery systems and finally doctors for clinical trials4. 
 
New drug discovery 
New drugs have been discovered from two major sources 
• Synthetic chemicals 
• Natural products including plants, animals and microbes 
The drug discovery process is responsible not only for the introduction of many 
new drugs to the market but also for the improvements in the therapy of many 
diseases. The drug development starts from receptor mapping, target identification 
and optimization, pharmacodynamic screening, pharmacokinetic optimization and 
ends in pre-clinical assessment to clinical assessment of the drug.1 
 
Techniques used 
Mass spectroscopy was used for the accurate determination of molecular mass in 
structural determination of chemical compounds. Non-validated screening methods 
are used to monitor the synthesis of active ingredients or to confirm their identity 
during discovery and preclinical research. Analytical methods are progressively 
optimized and a preliminary validation package is furnished as a part of the 
Investigational New Drug (IND) application before phase I safety trials are initiated. 
Recently the protein analysis was carried out by two-dimensional gel 
electrophoresis. The viable alternative approach is chromatographic separation of 
peptides with MS detection. Nanotechnology can provide substantial benefits to the 
drug discovery process by improving the understanding of materials/chemicals at the 
cellular/molecular level, enhanced detection, increased throughput, shorter time for 
the discovery of new drugs and precise use (nano litre scale) of precious reagents 
required to carry out screening of potential drugs, etc. 
Nano particles of Quantum Dots (QDs), Gold colloids and nano shells are used in 
detection of different biological components like proteins, strands of DNA with 
specific colours, immunoglobulin in whole blood, that possess the targets in drug 
discoveries.2-5 
In new drug discovery process the analytical R&D and analytical chemist play a 
key role. In R&D the chemists are involved in a wide range of activities like, 
• Characterization, optimization, selection of new drug candidates in the interface 
 between drug discovery and the early phase of drug development. 
• Development and analysis of new formulations and drug delivery systems. 
• New analytical method development for the Active Pharmaceutical Ingredient 
 (API) 
• Predicting shelf life of products 
• Development and optimization of new formulas and technical processes for the 
 pharmaceutical formulations required for clinical trials and the market.6 
 
The method development and validation process for pharmaceutical dosage form 
Analytical methods development and validation play important roles in the new 
drug discovery, development and manufacture of pharmaceuticals. 
The steps of method development and method validation depend upon the type of 
method being developed. However, the following steps are common to most types of 
analytical methods. 
• Method development plan definition 
• Background information gathering (nature of the sample, size of the sample, 
 proportion of the constituent to be determined) 
• Laboratory method development 
• Generation of test procedure 
• Methods validation protocol definition 
• Laboratory methods validation 
• Validated test method generation 
• Validation report 
A well-developed method should be easy to validate. A method should be 
developed with the goal to rapidly test preclinical samples, formulation prototypes 
and commercial samples. Ideally, the validation protocol should be written only 
following a thorough understanding of the method’s capabilities and intended use. 
The validation protocol will list the acceptance criteria that the method can meet. Any 
failure to meet the criteria will require that a formal investigation be conducted. The 
required validation parameters, also termed analytical performance characteristics, 
depend upon the type of analytical method. 
Pharmaceutical analytical methods are categorized into five general types: 
¾ Identification tests 
¾ Potency assays 
¾ Impurity tests: quantitative 
¾ Impurity tests: limit 
¾ Specific tests 
The first four tests are universal tests, but the specific tests such as particle-size 
analysis and x-ray diffraction are used to control specific properties of the API or the 
drug product.4 
Recent progress in method development has been largely based on the result of 
improvements in analytical instrumentation. This is especially true for 
chromatographs and detectors. Isocratic and gradient reverse-phase HPLC have 
evolved as the primary techniques for the analysis of non-volatile APIs. The HPLC 
detector of choice for many types of methods development is the photo-diode array 
(PDA) detector because it can be used for both quantitative and qualitative analysis. 
The use of a PDA detector to determine peak purity of the active ingredient in 
stressed samples greatly facilitates the development of stability-indicating assays. 
Gas chromatography remains the method of choice for the analysis of volatile 
compounds. Gas chromatography with mass spectroscopy detection is increased being 
used to identify impurities and to determine active ingredient peak purity in stressed 
samples. Advances in the use of non-destructive infrared (IR) and near infrared (near 
IR) spectroscopy and NMR techniques are particularly for method development 
scientists. 
The emphasis on the identification of trace impurities and degradants has lead to 
the increased use of hyphenated techniques such as liquid chromatography – mass 
spectroscopy (LC-MS) and liquid chromatography – nuclear magnetic resonance 
spectroscopy (LC-NMR).9 
According to ICH guidelines the parameters including specificity, accuracy, 
linearity, precision, range, detection limit, quantification limit, and robustness are 
required to validate a newly developed method. 
Only specificity is needed for an identification test. However, the full range of 
specificity, accuracy, linearity, and range, limit of detection (LOD), limit of 
quantification (LOQ), precision and robustness testing is needed for more complex 
methods such as quantitative impurity methods. 
 
Challenges in method development 
Common challenges that are encountered during method development and 
validation are 
¾ Lacking in robustness and the loss of efficiency during routine QC testing. 
¾ No sound knowledge in design and execution of forced - degradation stability 
 studies. 
¾ Lack in up-gradation of current regulatory standards 
¾ Insufficient monitoring and training programs.4, 7 
 
Validation 
 The word “Validation” means “Assessment” of validity or action of proving 
effectiveness.13 
 
Definitions 
 FDA defines validation as “establish the documented evidence which provides a 
high degree of assurance that a specific process will consistently produce a product of 
predetermined specifications and quantity attributes”. 
EUGMP define validation as “action of proving in accordance with the principle 
of Good Manufacturing Practice (GMP), that any material, activity or system actually 
lead to expected result”. 
AUSTRALIAN GMP defines validation as “the action of proving that any 
material, process, activity, procedure, system, equipment or mechanism used in 
manufacture or control can and will be reliable and achieve the desire and intended 
result”. 
 
Analytical Method Validation 
 Method validation is the documented successful evaluation of an analytical 
method that provides a high level of assurance that such method will consistently 
yield result that are accurate with in previously established specification. 
 
Types of Validation 
 The following are frequently required to be validated on a pharmaceutical process; 
Equipment, Environment, Materials, Methods, Controls, Process, Personnel’s, 
Facilities and Operating procedure. Based on these, the validation program comprises, 
• Equipment validation 
• Facility validation 
• Process validation 
• Cleaning validation 
• Analytical method validation 
 
Analytical Method Validation 
Method validation is the process to confirm that the analytical procedure 
employed for a specific test is suitable for its intended use. Analytical testing of a 
pharmaceutical product is necessary to ensure its purity, stability, safety and efficacy. 
Analytical method validation is an integral part of the quality control system. 
 Although a thorough validation cannot rule out all potential problems, the process 
of method development and validation should address the most common ones. 
 
Parameters used for assay validation 
 The validation of the assay procedure was carried using the following parameters; 
 
1. Specificity 
Definition 
 Specificity is the ability to asses unequivocally the analyte in the presence of 
impurities, degradants, matrix etc (components) which may be expected to be present. 
Lack of specificity of an individual analytical procedure may be compensated by 
other supporting analytical procedures. 
Determination 
 The demonstration of specificity requires that the procedure is unaffected by the 
presence of impurities or excipients. In practice this can be done by spiking the drug 
substance or product with appropriate levels of impurities or excipients and 
demonstrating that the assay result is unaffected by the presence of these extraneous 
materials. 
ICH Requirement 
 The ICH documents state that when chromatographic procedures are used, 
representative chromatograms should be presented to demonstrate the degree of 
selectivity, and peaks should be appropriately labeled. Peak purity tests (e.g., using 
diode array or mass spectrometry) may be useful to show that the analyte 
chromatographic peak is not attributable to more than one component. 
 
2. Accuracy 
Definition 
 The accuracy of an analytical procedure expresses the closeness of agreement 
between the value, which is accepted either as a conventional true value or an 
accepted reference value and the value found. 
 
 
Determination 
 In case of assay of a drug in a formulated product, accuracy may be determined by 
application of the analytical method to synthetic mixtures of the drug product 
components to which the known amount of analyte have been added within the range 
of the method. If it is not possible to obtain all drug product components, it may be 
acceptable either to add known quantities of the analyte to the drug product or to 
compare results with those of a second, well characterized method, the accuracy of 
which has been stated or defined. 
ICH Requirements 
 The ICH documents recommended that accuracy should be assessed using a 
minimum of nine determinations over a minimum of three concentration levels, 
covering the specified range (i.e., three concentrations and three replicates of each 
concentration). 
 
3. Precision 
Definition 
 The precision of an analytical procedure expresses the closeness of agreement 
between a series of measurements obtained from multiple sampling of the same 
homogenous sample under the prescribed conditions. The precision of an analytical 
procedure is usually expressed as the variance, standard deviation or coefficient of 
variation of a series of measurements. 
Determination 
 The precision of an analytical method is determined by assaying a sufficient 
number of aliquots of a homogeneous sample to be able to calculate statistically valid 
estimates of standard deviation or relative standard deviation. 
ICH Requirements 
 The ICH documents recommended that repeatability should be assessed using a 
minimum of nine determinations covering the specified range for the procedure (i.e., 
three concentrations and three replicates of each concentration or using a minimum of 
six determinations at 100 % of the test concentration). 
 
 
 
 
4. Linearity 
Definition 
 The linearity of an analytical procedure is its ability (within a given range) to 
obtain the test results which are directly proportional to the concentration (amount) of 
analyte in the sample. 
Determination 
 Linearity of an analytical procedure is established, using a minimum of five 
concentrations. It is established initially by visual examination of a plot of signals as a 
function of analyte concentration of content. If there appears to be a linear 
relationship, test results are established by appropriate statistical methods. (i.e., by 
calculation of a regression line by the method of least squares). 
ICH Requirements 
 ICH recommends that, for the establishment of linearity, a minimum of five 
concentrations normally be used. It is also recommended that the following minimum 
specified ranges should be considered. 
Assay of drug substance (or a finished product): from 80% to 120% of the test 
concentration. 
 
5. Limit of Detection (LOD) 
Definition 
 LOD is the lowest concentration of the substance that the method can detect but 
not necessarily quantify. LOD simply indicates that the sample is below or above a 
certain level. 
Determination 
 For non-instrumental methods, the detection limit is generally determined by the 
analysis of samples with known concentrations of analyte and by establishing the 
minimum level at which the analyte can be reliably detected. 
ICH Requirement 
 The ICH describes a common approach, which is to compare measured signal 
from samples with known low concentrations of analyte with those of blank samples. 
The minimum concentration at which the analyte can reliably be detected is 
established. 
Typically acceptable signal-to-noise ratios are 2:1 or 3:1. 
 
6. Limit of Quantification (LOQ) 
Definition 
 LOQ is the lowest concentration of the substance that can be estimated 
quantitatively with acceptable precision, accuracy and reliability by the proposed 
method. LOQ is determined by analysis of samples containing decreasing known 
quantity of the substance and determining the lowest level at which acceptable level 
of accuracy and precision is attained. 
ICH Requirement 
 The ICH describes a common approach, which is to compare measured signal 
from samples with known low concentrations of analyte with those of blank samples. 
The minimum concentration at which the analyte can reliably be quantified is 
established. Typical acceptable signal-to-noise ratios are 10:1. 
 
7. Range 
Definition 
 The range of an analytical procedure is the interval between the upper and lower 
concentration (amounts) of analyte in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. 
Determination 
 The range of the method is validated by verifying that the analytical method 
provides acceptable precision, accuracy and linearity when applied to samples 
containing analyte at the extremes of the range as well as within the range. 
 
8. Robustness 
Definition 
 The robustness of an analytical procedure is a measure of its capacity to remain 
unchanged by small but deliberate variations in methods parameters and provides an 
indication of its reliability during normal usage. 
Determination 
 The robustness of method is determined by performing the assay by deliberately 
altering parameters (-change in flow rate- ±10%, change in pH of mobile phase- 
±0.2%, change in wave length detection- ± 5nm) that the results are not influenced by 
the changes in the above parameters. 
9. Ruggedness 
Definition 
 The ruggedness of an analytical method is the degree of reproducibility of test 
results obtained by the analysis of the same samples under a variety of conditions, 
such as different laboratories, different analysts, different instruments, different lots of 
reagents, different elapsed assay times, different assay temperatures, different days, 
etc. 
Determination 
 The ruggedness of an analytical method is determined by the analysis of aliquots 
from homogeneous lots in different laboratories, by different analysts, using 
operational and environmental condition that may differ but are still within the 
specified parameters of the assay. The degree of reproducibility of the result is then 
determined as a function of assay variables. This reproducibility may be compared to 
the precision of assay under normal condition to obtain a measure of the ruggedness 
of the analytical method.  
 
High performance liquid chromatography (HPLC) 
 High performance liquid chromatography (HPLC) developed during 1960s as a 
direct offshoot of classical column liquid chromatography through improvements in 
the technology of columns and instrumental components (pumps, injection valves and 
detectors). Advantages of HPLC over traditional low-pressure column liquid 
chromatography include, 
1. Speed and improved resolution 
2. Greater sensitivity 
3. Re-usable columns 
4. Ideal for ionic species and large molecules (substances of  low volatility) 
5. Easy  sample recovery2,9,10 
 HPLC has many modes (adsorption, partition, ion-exchange, ion-pair, size-
exclusion, chiral, affinity) of separation which are selected based on component 
nature and type of analysis. Though many modes are available in HPLC, the RP-
HPLC is widely used in pharma industry as most of API is polar in nature. 
 
 
 
Method development in RP-HPLC 
 For reverse phase chromatography (RPC), the stationary phase is less polar than 
the mobile phase. The mobile phase is a mixture of organic and aqueous phase. In 
RPC, the solutes are eluted in order of their decreasing polarities. These are prepared 
by treating the surface of silanol group with an organo-chloro silane reagent. It 
includes, 
 Retention in RP-HPLC 
 Selectivity in RP-HPLC 
 The RPC retention of a compound is determined by its polarity, experimental 
conditions, mobile phase, column, temperature3, 4 
 Three main variables can be used in RPC to change selectivity (α) for neutral 
samples, i.e. 
 
Mobile phase composition 
    Solvent strength selectivity 
 Solvent type selectivity 
Column type 
Temperature 
The four primary techniques for quantification are, 
i. Normalized peak area method 
ii. External standard method 
iii. Internal standard method 
iv. Method of standard addition 
v. Calibration by standards3, 4 
 
Normalized peak area method 
 The area percent of any individual peak is referred to the normalized peak area. 
This technique is widely used to estimate the relative amounts of small impurities or 
degradation compounds in a purified material and in this method; the response factor 
for each component is identical. 
 
 
 
 
External standard method 
 This method includes injection of both standard solution and unknown sample. 
The concentration of unknown is determined graphically from a calibration plot or 
numerically using response factors. 
 A response factor (Rf) (sometimes called a sensitivity factor) can be determined 
for each standard as follows. 
       Standard area (peak height) 
    Rf = ----------------------------------- 
         Standard concentration 
 The external standard approach is preferred for most samples in HPLC that do not 
require extensive sample preparation. For good quantitation using external standards, 
the Chromatographic conditions must remain constant during the separation of all 
standards and samples. External standards are often used to ensure that the total 
Chromatographic system (equipment, column conditions) is performing properly and 
can provide reliable results. 
 
Internal standard method 
 The internal standard is a different compound from the analyte but one that is well 
resolved in separation. The internal standard should be chosen to mimic the behaviour 
of the sample compound. One of the main reasons for using internal standard is for 
samples requiring significant pre-treatment or preparation. 
 
Method of standard addition 
 The method of standard addition can be used to provide a calibration plot for 
quantitative analysis. It is most often used in trace analysis. An important aspect of 
the method of standard addition is that the response prior to spiking additional 
analytes should be high enough to provide reasonable S/N ratio (>10), otherwise the 
result will have poor precision.5, 8 
 
 
 
 
Calibration by standards 
 Calibration curves for each component are prepared from pure standards, using 
identical injection volumes of operating conditions for standards and samples. The 
concentration of solute is read from its curve if the curve is linear. 
   X = K x Peak Area 
 Where, X = Concentration 
   K = Proportionality constant  
 In this evaluation method, only the area of the peaks of interest is measured. 
Relative response factors must be considered when converting areas to volume and 
when the response of a given detector differs for each molecular type of compounds. 
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AIM AND PLAN OF WORK 
Aim 
 Ayurveda, the ancient system of herbal medicine is growing popular worldwide, 
but a number of factors such as standardization and stability studies are still at an 
infant stage for an ayurvedic product. The drug analysis plays an important role in the 
development of drugs, their manufacture and therapeutic use. These drugs may be in 
single component or multi-component dosage forms. The multi-component dosage 
forms prove to be effective due to the combined mode of action on the body. The 
complexity of dosage forms including multiple drug entities possesses considerable 
challenge to the analytical chemist during the development of assay procedures for 
ayurvedic formulations. 
For the estimation of drugs present in multi-component ayurvedic formulations, 
chromatographic methods are considered to be more suitable than spectrophotometric 
methods due to its very high sensitivity. 
The present study deals with the development of new RP-HPLC method for the 
estimation of gallic acid and ellagic acid  in the triphala churnam tablet formulation 
and then validation of the method as per ICH guidelines (International Conference on 
Harmonization of Technical Requirement for Registration of Pharmaceuticals for 
Human use). 
Plan 
1. Study the physicochemical properties of drug (pH, solubility and molecular  weight. 
2. Selection of chromatographic conditions (mobile phase, column, flow rate, etc.) 
3. Optimization of the method. 
4. Study of system suitability parameters. 
5. Validation of proposed method. 
6. Applying developed method to marketed formulation. 
 
 
 
 
 
DRUG PROFILE 
GALLIC ACID26-28 
Chemical structure 
                                              
Molecular formula:  C7H6O5.  
IUPAC name:   3, 4, 5-Trihydroxybenzoic acid. 
Molecular weight:  170.12 
Density:     1.7g/cm3(anhydrous) 
Melting point:   250 0 C, 523 K, 482 0 F. 
Stability:     Stable under ordinary conditions of use and storage. 
Description: 
Pure gallic acid is colorless crystalline organic powder. Gallic acid occurs as a 
free molecule or as part of a tannin molecule. 
Distribution: 
Gallic aid is found in almost all plants. Plants known for their high gallic acid 
content include gallnuts, grapes, tea, hops and oak bark. 
Protein binding: 
Gallic acid does not combine with protein and has therefore no astringent taste. 
Solubility in water: 
It is freely soluble in water at 20 0C and soluble in methanol (when gallic acid 
treated with methanol it undergoes methanolysis and forms methylgallates). 
Properties: 
Gallic acid seems to have anti-fungal and anti-viral properties. Gallic acid acts as 
a antioxidant and helps to protect our cells against oxidative damage. Gallic acid was 
found to show cytotoxicity against cancer cells, without harming healthy cells. Gallic 
acid is used a remote astringent in case of internal haemorrhage. Gallic acid is also 
used to treat albuminuria and diabetes. Some ointment to treat psoriasis and external 
haemorrhoids contains gallic acid. 
 
  
ELLAGIC ACID29-33 
Chemical structure 
               
Molecular formula: C14H6O8   
IUPAC name:  4, 4', 5, 5', 6, 6'-hexahydrodiphenic acid 2, 6, 2', 6'-diulactone 
Molecular weight: 302.197  
Description:   Gray to slightly beige crystalline powder 
Density:    1.67 g/cm³ 
Melting point:  > 350 0C 
Solubility:   Soluble in methanol, and slightly soluble in water. 
Stability:    Stable under normal conditions. 
Purity (HPLC):  95.0% min 
Properties: 
Ellagic acid has antioxidant, anti-mutagen and anti-cancer properties. Studies have 
shown the anti-cancer activity on cancer cells of the breast, oesophagus, skin, colon, 
prostate and pancreas. More specifically, ellagic acid prevents the destruction of P53 
gene by cancer cells. Ellagic acid can bind with cancer causing molecules, thereby 
making them inactive. In their study The effects of dietary ellagic acid on rat hepatic 
and esophageal mucosal cytochromes P450 and phase II enzymes. Ahn D et al 
showed that ellagic acid causes a decrease in total hepatic mucosal cytochromes and 
an increase in some hepatic phase II enzyme activities, thereby enhancing the ability 
of the target tissues to detoxify the reactive intermediates. Ellagic acid showed also a 
chemoprotective effect against various chemically induced cancers. A study by 
Thresiamma KC and Kuttan R.Indian (Indian Journal Physiology and Pharmacology, 
1996 October) indicate that oral administration of ellagic acid by rats can circumvent 
the carbon tetrachloride toxicity and subsequent fibrosis of the liver. 
 
 
 
Mode of action: 
Ellagic acid is a scavenger of cancer-causing chemicals, making them inactive, 
inhibiting the ability of other chemicals to cause mutations in bacteria. Additionally, 
Ellagic Acid prevents binding of carcinogens to DNA, and reduces the incidence of 
cancer in cultured human cells exposed to carcinogens. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND INSTRUMENTS 
Instruments 
 UV-Visible spectrometer:  Elico-sl 164 
 HPLC:       Schimadzu, prominence 
 Sonicator:      Bandelin 
 Rotatory shaker:    Remi instrument ltd 
 Centrifuge apparatus:   Remi instrument 
 Analytical balance:   Metler 
 PH meter:      Elico PH meter Li 127 
HPLC Instrument description: 
Reverse phase HPLC was performed on isocratic HPLC pump. 
Materials 
Gallic acid marker compound:    Indofine, Inc, USA. 
Ellagic acid marker comound:    Indofine, Inc, USA. 
Triphala churnam uncoated tablets 500 mg: Procured from local market 
Chemicals 
Methanol HPLC grade 
 Ortho phosphoric acid AR grade 
 Water Milli-Q-water 
Method development for assay: 
 The plan of work was designed into following parts. 
HPLC Method Development: 
Material and method employed 
The method development and optimization of chromatographic condition were 
 Sample type 
 Solubility 
 Selection of wavelength 
 Selection of initial condition for separation 
 Optimization of chromatographic condition 
 Effect of ratio of mobile phase and its strength 
 Effect of column change 
 
 
 
METHOD DEVELOPMENT 
Method development and optimization of chromatographic conditions for Gallic 
acid: 
Sample type 
Gallic acid is a natural product having a molecular weight of 170.12 and contain 
COOH group in structure. 
Solubility 
Gallic acid is freely soluble in water and soluble in methanol. 
When gallic acid is treated with methanol it converts to methylgallate. This 
phenomenon is suitable for only less amounts of gallic acid. But this is inconvenient 
for screening large numbers of samples and cannot be employed in labs due to high 
pressure reaction condition.26  
Then different dilutions were checked for solubility of gallic acid in water. Finally 
water was selected to make dilution for assay method in the present work. 
Selection of wavelength 
The sensitivity of HPLC depends upon proper selection of wave length of 
detection. An ideal wavelength is one that gives good response for the drug to be 
detected. In order to determine the proper wave length of gallic acid in diluents, 
spectra were scanned on UV-Visible spectrometer in the range of 200 nm- 400 nm 
against diluents as blank. The λ max was found to be 270 nm. 
Selection of initial chromatographic conditions 
Appropriate selection of chromatographic method depends upon the characteristic 
nature of the sample (ionic or ionisable or neutral), its molecular weight and 
solubility. The nature of gallic acid is organic acid. Hence reverse phase 
chromatography is used. The reverse phase HPLC was selected for initial 
chromatographic condition because of its simplicity and suitability. 
Initial chromatographic conditions 
Columns: 4.6 x 250 mm column containing packing of octadecylsilane chemically 
bounded to porous silica or ceramic micro particles, of 5 µm. 
Temperature:  Room temperature 
Flow rate:   1 ml/min 
Injection volume: 20 µl 
Wave length:  270 nm 
In RP-HPLC pH of the mobile phase ranges in between 2 to 8, in this case pH of 
gallic acid was 4.5 and according to Handerson hassle batch equation pH of the 
mobile phase should be adjusted above 2 of the pKa value of the drug substance. Here 
pKa of the gallic acid 4.5 was  hence buffer pH was adjusted to 5.1 as 97.5% of gallic 
acid was ionisable under RP condition and eluted was carried out by using phosphate 
buffer. 
Mobile phase selection 
The main requirement of mobile phase is that it has to dissolve the analytes upto 
the concentration suitable for detection. Acetonitrile having a UV cut off < 200 nm, 
refractive index – 1.3441, viscosity- 0.38, boiling point- 81.6 0C, polarity value- 5.8 
and solvent miscibility number of 11 as it should not be greater than 17. 
Selection of buffer 
In reverse phase chromatography mobile phase pH values are usually between 2 
and 7.2. as gallic acid was ionizable under reverse phase condition having –COOH as 
a functional group with pKa between 4.5 to 10. 
Selection of column 
In this method we were used Symmetry Shield TM RP 18, C 18 4.6 X 250 mm, 5 
µm column. 
UV- Spectra 
 
Trial-I 
Objective: To develop a method for the assay of gallic acid by HPLC. 
Chromatographic conditions: 
Column:  4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   270 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water) 
     (20: 80). 
Observation 
In this trail symmetry shield was taken, gallic acid peak eluted at 6.097th minute. 
Tailing was observed with the analyte peak. 
Chromatogram 
 
  
 
 
 
 
Trial-II 
Objective: to develop a method for the assay of gallic acid by HPLC. 
Chromatographic conditions 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   270 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)    
     (40: 60). 
Observation 
In this trail symmetry shield column C 18 was taken, gallic acid eluted at 4.503th 
minute but tailing also increased to 1.9 and hence gone for further trail as it was not 
satisfactory. 
Chromatogram 
 
 
 
 
 
 
Trial-III 
Objective: To develop a method for the assay of gallic acid by HPLC. 
Chromatographic conditions: 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles,     5 µm. 
Column temperature: room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   270 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)  
     (60: 40). 
Observation: 
 In this trail we had taken symmetry shield column C18, gallic acid peak was 
eluted at 3.52th minute but elution of solute was not satisfactory hence underwent for 
further trail. 
Chromatogram: 
 
 
 
 
 
Trial-IV 
Objective: to develop a method for the assay of gallic acid by HPLC. 
Chromatographic conditions: 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   270 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)    
     (80: 20). 
Observation: 
 In this trail we had taken symmetry shield column C-18, the peak was eluted at 
2.81th minute which showed very sharp peak and hence we proceed further with this 
method. 
Chromatogram 
 
 
 
 
 
Method development and optimization of chromatographic conditions for Ellagic 
acid 
Sample type 
Ellagic acid is a natural product having a molecular weight 302.197 and contain 
C==O group in structure. 
Solubility 
According to literature survey, ellagic acid is freely soluble in methanol and 
slightly soluble in water. Then different dilution of was check for solubility of ellagic 
acid in methanol. Finally methanol was selected to make dilution for assay method in 
the present work. 
Selection of wavelength 
The sensitivity of HPLC depends upon proper selection of wave length of 
detection. An ideal wavelength is one that gives good response for the drug to be 
detected. In order to determine the proper wave length of ellagic acid in diluents, 
spectra were scanned on UV-Visible spectrometer in the range of 200 nm- 400 nm 
against diluents as blank. The λ max was found to be 254 nm. 
Selection of initial chromatographic conditions 
Appropriate selection of chromatographic method depends upon the characteristic 
nature of the sample (ionic or ionisable or neutral), its molecular weight and 
solubility. The nature of ellagic acid is organic acid. Hence reverse phase 
chromatography is used. The reverse phase HPLC was selected for initial 
chromatographic condition because of its simplicity and suitability. 
Initial chromatographic conditions: 
Columns: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Temperature:  Room temperature 
Flow rate:   1 ml/min 
Injection volume: 20 µl 
Wave length:  254 nm 
In RP-HPLC pH of the mobile phase ranges in between 2 to 8, in this case pH of 
ellagic acid was 5 - 6 and according to Handerson hassle batch equation pH of the 
mobile phase should be adjusted above 2 of the pKa value of the drug substance. Here 
pKa of the ellagic acid 5-10 was  hence buffer pH was adjusted to 5.1 as 95 % of 
ellagic acid was ionisable under RP condition and eluted was carried out by using 
phosphate buffer. 
Mobile phase selection 
The main requirement of mobile phase is that it has to dissolve the analytes upto 
the concentration suitable for detection. Acetonitrile having a UV cut off < 200 nm, 
refractive index – 1.3441, viscosity- 0.38, boiling point- 81.6 0C, polarity value- 5.8 
and solvent miscibility number of 11 as it should not be greater than 17. 
Selection of buffer 
In reverse phase chromatography mobile phase pH values are usually between 2 
and 7.2. As ellagic acid was ionizable under reverse phase condition having –COOH 
as a functional group with pKa between 4.5 to 10 
Selection of column 
In this method we were used Symmetry Shield TM RP 18, C 18 4.6 X 250 mm, 5 
µm column. 
UV- Spectra 
 
 
 
Trial-I 
Objective: To develop a method for the assay of ellagic acid by HPLC. 
Chromatographic conditions 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   254 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)        
     (20: 80). 
Observation 
In this we trail symmetry shield was taken, ellagic acid peak eluted at 13.94th 
minute. Tailing was observed with the analyte peak. 
Chromatogram 
 
 
 
 
 
 
Trial-II 
Objective: to develop a method for the assay of ellagic acid by HPLC. 
Chromatographic conditions: 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   254 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)  
     (40: 60). 
Observation 
In this trail symmetry shield column C 18 was taken, ellagic acid eluted at 6.99th 
minute but tailing also increased to 1.5 and hence gone for further trail as it was not 
satisfactory. 
Chromatogram 
 
 
 
 
 
 
Trial-III 
Objective: to develop a method for the assay of ellagic acid by HPLC. 
Chromatographic conditions: 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   254 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)     
     (60: 40). 
Observation 
In this trail we had taken symmetry shield column C18, ellagic acid peak was 
eluted at 5.903th minute but elution of solute was not satisfactory hence underwent for 
further trail. 
Chromatogram 
 
 
 
 
 
 
Trial-IV 
Objective: to develop a method for the assay of ellagic acid by HPLC. 
Chromatographic conditions 
Column: 4.6 X 250 mm column containing packing of octadecyl silane chemically 
bounded to porous silica or ceramic micro particles, 5 µm. 
Column temperature: Room temperature. 
Flow rate:    1.0 ml/min. 
Injection volume:  20 µl. 
Wavelength:   254 nm. 
Mobile phase:   Acetonitrile: buffer (0.01 %v/v O-phosphoric acid in water)    
     (80: 20). 
Observation 
In this trail we had taken symmetry shield column C-18, the peak was eluted at 
4.50th minute which showed very sharp peak and hence we proceed further with this 
method. 
Chromatogram 
 
 
 
 
 
 
QUANTITATION 
For Gallic acid 
 The fixed chromatographic conditions were applied for the estimation of gallic 
acid in formulation by RP-HPLC method. 
 
Preparation of mobile phase: 
 1 ml of ortho-phosphoric acid was dissolved in 1000 ml of milli-Q-water. Filter 
and degassed by sonication and mixed the Acetonitrile and buffer in the ratio of 80: 
20 v/v. 
 
Preparation of standard solution 
 10 mg of gallic acid were taken in a 10 ml standard flask and dissolved in 5mL of 
milli-Q-water. The volume was then made up to 10 ml with milli-Q-water to get a 
concentration of 1mg/ml. Further dilutions were made by taking 0.2 ml, 0.4 ml, 0.6 
ml, 0.8 ml, 1 ml and 1.2 ml of working standard solution of gallic acid and then 
making up the volume to 10 ml with mobile phase. This resulted in concentrations of 
20μg/ml, 40μg/ml, 60μg/ml, 80μg/ml, 100μg/ml and 120μg/ml of gallic acid 
respectively. 
 
Preparation of formulation solution 
 20 tablets were weighed and powdered. From that 1.6403 gm of powder was 
weighed into a 10 ml standard flask and extracted with 10 ml of milli-Q-water by 
sonication for 20 minutes. From that 0.8 ml was diluted to 10 ml with mobile phase. 
 
Recording of chromatograms 
 The standard solutions were injected after a steady baseline was obtained. The 
standard chromatograms were recorded and the peak areas of standard chromatograms 
were noted. A calibration graph was plotted using peak area Vs concentration. 
 Then the formulation solution was injected and amount of gallic acid present in 
the formulation was calculated from the calibration curve. The amount of gallic acid 
present in each tablet formulation was found to be 3.06 mg. 
 
 
For Ellagic acid 
 The fixed chromatographic conditions were applied for the estimation of ellagic 
acid in formulation by RP-HPLC method. 
 
Preparation of mobile phase: 
 1 ml of ortho-phosphoric acid was dissolved in 1000 ml of milli-Q-water. Filter 
and degassed by sonication and mixed the Acetonitrile and buffer in the ratio of 80: 
20 v/v. 
 
Preparation of standard solution 
10 mg of ellagic acid were taken in a 10 ml standard flask and dissolved in 5mL 
of methanol. The volume was then made up to 10 ml with methanol to get a 
concentration of 1mg/ml. Further dilutions were made by taking 0.2 ml, 0.4 ml, 0.6 
ml, 0.8 ml, 1 ml and 1.2 ml of working standard solution of ellagic acid and then 
making up the volume to 10 ml with mobile phase. This resulted in concentrations of 
20μg/ml, 40μg/ml, 60μg/ml, 80μg/ml, 100μg/ml and 120μg/ml of ellagic acid 
respectively. 
 
Preparation of formulation solution 
 20 tablets were weighed and powdered. From that 5.191 gm of powder was 
weighed into a 10 ml standard flask and extracted with 10 ml of methanol by 
sonication for 20 minutes. From that 0.8 ml was diluted to 10 ml with mobile phase. 
 
Recording of chromatograms 
 The standard solutions were injected after a steady baseline was obtained. The 
standard chromatograms were recorded and the peak areas of standard chromatograms 
were noted. A calibration graph was plotted using peak area Vs concentration. 
 Then the formulation solution was injected and amount of ellagic acid present in 
the formulation was calculated from the calibration curve. The amount of ellagic acid 
present in each tablet formulation was found to be 0.955 mg. 
 
 
 
VALIDATION 
Validation of the developed method 
For Gallic acid 
 The RP-HPLC method was validated in terms of parameters like accuracy, 
linearity, precision, range, detection limit, quantification limit, robustness, 
ruggedness, system suitability, etc. For all the parameters percentage relative standard 
deviation values were calculated. 
 
System suitability 
 The system suitability studies were carried out. The parameters include 
asymmetry factor, column efficiency, number of theoretical plates, etc. These 
parameters are shown in table. 
S. NO: RT(min) Peak area  Asymmetry 
1 2.733 2570175 1.636 
2 2.737 2571245 1.636 
3 2.727 2590146 1.636 
4 2.723 2580176 1.591 
5 2.710 2591215 1.636 
AVG 2.726 2580591 1.627 
SD 0.016263 10002.25 0.020125 
% RSD 0.596605 0.387595 1.236 
 
Specificity 
 A study of establish the interferences effecting the elution of peak of gallic acid 
was conducted. By injecting blank, standard solution and sample solutions to HPLC, 
the resultant chromatograms were not showing any interference to elution of gallic 
acid peak at 2.81 min. this indicates that the other ingredients present in the 
formulation do not interfere in estimation of gallic acid by this method.   
 
Accuracy 
The accuracy of the method was checked by intercepting calibratioin curve (which 
is plotted between the area under curve on y- axis and concentration of standard 
solutions on x-axis) with the sample area under curve which is obtained when 
injecting the 80 μg/ml, 100 μg/ml and 120 μg/ml standard solutions to HPLC. The % 
recovery for gallic acid was found to be 98.5%, 99.5% and 99.15% respectively.  
 
 Conc  
(μg) Peak area Average 
Recovery 
(μg) % Recovery 
2994344 
2995545 80  
2996303 
2995397 78.8 98.5 
3782275 
3781005 100  
3785282 
3782854 99.5 99.5 
4522803 
4524971 120  
4522664 
4523479 118.98 99.15 
 
Linearity 
The standard stock solution was diluted further to get a concentration in the range 
of 20µg/ml to 120µg/ml of gallic acid. Each concentration was injected in triplicate 
and the average area was calculated. A calibration curve was plotted using peak area 
Vs concentration. The calibration plot is shown in figure-1. The correlation 
coefficient was found to be 0.999. 
 
Conc (µg/ml) Peak area 
20 777838 
40 1510959 
60 2266923 
80 2990856 
100 3807734 
120 4561012 
AVG 2662554 
SD 1421352 
 
 
 
  
 
 
  
Correlation coefficient (R2)  = 0.999 
Slope       = 38027 
Straight line equation (y)  = 38027x 
 
Precision 
 Precision of an analytical method is the degree of agreement among individual test 
results when the method is applied repeatedly. 
 
Repeatability of injections 
Repeatability studies were done by consequently injecting the standard drug 
solution of gallic acid. % RSD of peak areas was calculated and shown in the table. 
 
S.No RT(min) Peak area  
1 2.81 3025854 
2 2.81 3024905 
3 2.81 3025478 
4 2.81 3023431 
5 2.813 3025171 
AVR 2.8106 3024968 
SD 0.001342 0.929064 
% RSD 0.047735 0.030713 
 
Limit of detection 
The lowest detection limit was calculated from the slope and was found to be 
6.13µg/ml. 
 
Limit of quantification 
 The lowest limit of quantification was calculated from the slope and was found to 
be 18.57µg/ml. 
 
Robustness 
 For demonstrating the robustness of the method, the following optimized 
conditions were slightly changed. By changing ±3 units in temperature (27 0 c). 
 
Temp (0C) RT Peak area 
24 3.117 4364371 
27 2.813 3931075 
30 2.567 3597353 
 
Ruggedness 
 For demonstrating ruggedness of the method, the standard drug solution was 
injected in triplicate by two different analysts. 
 
Analyst Peak area Avarage % RSD 
1 3948644 
2 3953310 
3950977 0.059 
 
 
 
 
 
 
 
 
For ellagic acid 
 The RP-HPLC method was validated in terms of parameters like accuracy, 
linearity, precision, range, detection limit, quantification limit, robustness, 
ruggedness, system suitability, etc. For all the parameters percentage relative standard 
deviation values were calculated. 
 
System suitability 
 The system suitability studies were carried out. The parameters include 
asymmetry factor, column efficiency, number of theoretical plates, etc. These 
parameters are shown in table. 
 S. No RT (min) Peak area  Asymmetry 
1 4.533 3247279 1.813 
2 4.54 3241193 1.727 
3 4.54 3203093 1.727 
4 4.55 3182422 1.727 
5 4.553 3193179 1.697 
AVG 4.5432 3213433 1.7382 
SD 0.014142 38254.48 0.043786 
% RSD 0.311281 1.190 2.519 
 
Specificity 
 A study of establish the interferences effecting the elution of peak of gallic acid 
was conducted. By injecting blank, standard solution and sample solutions to HPLC, 
the resultant chromatograms were not showing any interference to elution of gallic 
acid peak at 2.81 min. this indicates that the other ingredients present in the 
formulation do not interfere in estimation of gallic acid by this method. 
 
Accuracy 
The accuracy of the method was checked by interception of calibratioin curve 
(which is plotted between the area under curve on y- axis and concentration of 
standard solutions on x-axis) with the sample area under curve (which is obtained 
when injecting the sample solution to HPLC). The % recoveries for ellagic acid were 
98.95%, 100.2%, 100.15%. 
 
Conc.  
(μg/ml) Peak area Average 
Recovery 
(μg) 
% 
Recovery 
3426566 
3428197 80 
3427794 
3427519 79.16 98.95 
4335685 
4343386 100 
4331503 
4336858 100.2 100.2 
120 5204539 5203447 120.18 100.15 
5204397  
5201406 
   
 
Linearity 
 The standard stock solution was diluted further to get a concentration in the range 
of 20µg/ml to 120µg/ml of ellagic acid. Each concentration was injected in triplicate 
and the average area was calculated. A calibration curve was plotted using peak area 
Vs concentration. The calibration plot is shown in figure. The correlation coefficient 
was found to be 0.999. 
 
Conc (µg/ml) Peak area 
20 882749 
40 1745738 
60 2616383 
80 3466229 
100 4316739 
120 5188323 
AVG 3036027 
SD 1608430 
 
 
 
 
 Correlation coefficient (R2) = 0.999 
Slope       = 43298 
Straight line equation  y = 43298x 
 
Precision 
 Precision of an analytical method is the degree of agreement among individual test 
results when the method is applied repeatedly. 
 
Repeatability of injections 
Repeatability studies were done by consequently injecting the standard drug 
solution of ellagic acid. % RSD of peak areas was calculated and shown in the table. 
 
S. No RT (min) Peak area 
1 2.81 3025854 
2 2.81 3024905 
3 2.81 3025478 
4 2.81 3023431 
5 2.813 3025171 
AVG 2.8106 3024968 
SD 0.001342 929.0644 
% RSD 0.047735 0.0307 
 
Limit of detection 
 The lowest detection limit was calculated from the slope and was found to be 
3.744µg/mL. 
 
Limit of quantification 
 The lowest limit of quantification was calculated from the slope and was found to 
be be 16.84µg/mL. 
 
Robustness 
 For demonstrating the robustness of the method, the following optimized 
conditions were slightly changed. By changing the temperature (27 0 c) ±3 units. 
 Temp (0C) RT (min) Peak area  
24 5.417 5538435 
27 4.547 4728177 
30 3.917 4103664 
 
Ruggedness 
 For demonstrating ruggedness of the method, the standard drug solution was 
injected in triplicate by two different analysts. 
 
Analyst Peak area Avarage % RSD 
1 8809092 
2 8806864 
8807978 0.01788 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHROMATOGRAMS 
For Gallic acid 
System suitability 
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Assay of samples 
 
  
inj-01_Sample-01 
inj-01_sample-02 
inj-04_Standard-04 
inj-05_Standard-05
For Ellagic acid 
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RESULTS AND DISCUSSION 
For gallic acid 
Of the various proportions of acetonitrile and buffer (0.1% orthophophoric acid in 
milli-Q-water) tried, that containing 80: 20 v/v of acetonitrile and buffer was found to 
be most suitable one. In this system, gallic acid was eluted (Rt= 2.81 min) in the 
presence of other compounds in the sample extract. The absorbance maximum (λmax) 
for gallic acid was 270 nm. 
 
Validation 
 The HPLC method was validated in terms of precision, repeatability and accuracy. 
The method is specific as it is well-resolved gallic acid with a retention time (Rt) 
value of 2.81 min in the presence of other components in the sample of triphala 
churnam tablet formulation. 
The relationship between the concentration of standard solution and the peak 
response was linear with in the concentration range of 20μg/ml to 120μg/ml with a 
correlation coefficient of 0.999. 
y= 38027x 
 The precision was studied by repeated injections of the same concentration five 
times (% CV = 0.0307). 
 Accuracy of the developed method was determined at three levels (80%, 100% 
and 120%). The % recoveries were found to be 98.5%, 99.5% and 99.15%. The limit 
of detection for gallic acid was calculated from the standard deviation of the linear 
curve and the slope. The value was 6.13µg/ml. 
 The limit of quantification for gallic acid was calculated from the standard 
deviation of the linear curve and the slope. The value was 18.57µg/ml. 
 There is allowable variation in temperature which indicates that method is robust 
enough. 
 The low RSD value (0.32) for percent assay of test preparation revealed that the 
proposed method is rugged. The chromatogram of sample showed a single peak at the 
retention time of gallic acid indicating that there is no interference of the changing the 
persons for injecting the sample to the instrument. 
 The amount of gallic acid present in the formulation was found to be 3.06 mg. 
 
For ellagic acid 
 Of the various proportions of acetonitrile and buffer (0.1% orthophophoric acid in 
milli-Q-water) tried, that containing 80: 20 v/v of acetonitrile and buffer was found to 
be most suitable one. In this system, ellagic acid was eluted (Rt= 4.5min) in the 
presence of other compounds in the sample extract. The absorbance maximum (λmax) 
for ellagic acid was 254 nm. 
 
Validation  
 The HPLC method was validated in terms of precision, repeatability and accuracy. 
The method is specific as it is well-resolved ellagic acid with a retention time (Rt) 
value of 4.5 min in the presence of other components in the sample of triphala 
churnam tablet formulation. 
The relationship between the concentration of standard solution and the peak 
response was linear with in the concentration range of 20μg/ml to 120μg/ml with a 
correlation coefficient of 0.999. 
y= 43298x 
 The precision was studied by repeated injections of the same concentration 5 
times (% CV = 0.0571). 
 Accuracy of the developed method was determined at three levels (80%, 100% 
and 120%). The recoveries were found to be 98.95%, 100.2% and 100.15%. 
 The limit of detection for the ellagic acid was calculated from the standard 
deviation of the linear curve and slope. That was found to be 3.744µg/mL. 
 The limit of quantification for the ellagic acid was calculated from the standard 
deviation of the linear curve and slope. That was found to be 16.84µg/ml. 
 There is allowable variation in temperature, which indicates that method is robust 
enough. 
 The low RSD value (0.0179) for percent assay of test preparation revealed that the 
proposed method is rugged. The chromatogram of sample showed a single peak at the 
retention time of ellagic acid indicating that there is no interference of the changing 
the persons for injecting the sample to the instrument. 
 The amount of ellagic acid present in the formulation was found to be 0.955 mg. 
 
 
Method validation parameters for the estimation of gallic acid and ellagic acid by 
the HPLC method 
S. No Validation Parameters Gallic acid Ellagic acid 
1. System suitability (asymmetry % CV) 1.236 2.52 
2. Specificity Specific Specific 
3. Linearity (correlation coefficient R2) 0.999 0.999 
4. Precision (% CV) (n = 5) 0.0307 0.0571 
5. Limit Of Detection (LOD) 6.13 µg 3.744 µg 
6. Limit Of Quantitation (LOQ) 18.57 µg 16.84 µg 
7. Robustness (variation in temperature) Robust Robust 
8. Ruggedness (% CV) 0.32 0.0179 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
For gallic acid 
 A simple reverse phase high performance liquid chromatographic method 
exploying symmetry shield C-18 column has been developed for analysis of gallic 
acid. Good separation was achieved by employing an isocratic system using 
acetonitrile and 0.01 % phosphate buffer. The detection was carried out at 270 nm. 
The method was validated for linearity, accuracy, precision, robustness and 
ruggedness. The elution was carried out with a mixture of acetonitrile and phosphate 
buffer pH adjusted to 4.5 and the ratio 80: 20 at a constant flow rate 1 ml/min. the 
analytical wavelength was 270 nm. 
 The developed HPLC method is simple, accurate and reproducible the following 
advantages. It uses simple symmetry shield C-18 column under less consumption of 
the mobile phase consist of acetonitrile and phosphate buffer (pH 4.5) and also less 
run time. So this method can be used as a routine analytical tool for the analysis of 
gallic acid in herbal formulations. In the present study the gallic acid content of 3.06 
mg per tablet was observed in triphala churnam tablet formulation. 
For ellagic acid 
 A simple reverse phase high performance liquid chromatographic method 
exploying symmetry shield C-18 column has been developed for analysis of ellagic 
acid. Good separation was achieved by employing an isocratic system using 
acetonitrile and 0.01 % phosphate buffer. The detection was carried out at 254 nm. 
The method was validated for linearity, accuracy, precision, robustness and 
ruggedness. The elution was carried out with a mixture of acetonitrile and phosphate 
buffer pH adjusted to 4.5 and the ratio 80: 20 at a constant flow rate 1 ml/min. the 
analytical wavelength was 254 nm. 
 The developed HPLC method is simple, accurate and reproducible the following 
advantages. It uses simple symmetry shield C-18 column under the less consumption 
of mobile phase consist of acetonitrile and phosphate buffer (pH 4.5) and also less run 
time. So this method can be used as a routine analytical tool for the analysis of ellagic 
acid in herbal formulations. In the present study the ellagic acid content of 0.955 mg 
per tablet was observed in triphala churnam tablet formulation. 
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